Word

T'SUMOYL

Status

Registered

Status Code

700

Status Date

Tuesday, November 19, 2019

Serial Number

79246128

Registration Number

5911070

Registration Date

Tuesday, November 19, 2019

Mark Type

4000

Filing Date

Tuesday, September 18, 2018

Published for Opposition

Tuesday, September 3, 2019

Trademark Owner History

Clinuvel (UK) Ltd - Original Registrant

Classifications

3 Non-medicated skin care preparations; cosmetic preparations for skin care; cosmetic preparations for skin care, based on analogues of melanocyte stimulating hormone (MSH), in particular afamelanotide; cosmetic oils; cosmetic skin creams; skin care creams, lotions and oils for cosmetic purposes; wrinkle removing skin care preparations; cosmetic sunscreen preparations; waterproof sunscreen; sunscreen preparations; sunscreen creams and lotions; cosmetics for protecting the skin from sunburn; sunblock lotions; cosmetic sun barriers; sun creams; cosmetic preparations for protecting the skin from the sun's rays; sun care lotions; cosmetic compounds for skin care after exposure to the sun's rays; after-sun milks, creams, lotions and moisturizers; sun skin bronzers; sun-tanning preparations; cosmetics for tanning the skin including preparations for tanning without sunlight, containing analogues of melanocyte stimulating hormone (MSH), in particular afamelanotide; cosmetics for tanning the skin including preparations for tanning without sunlight, not containing analogues of melanocyte stimulating hormone (MSH), in particular afamelanotide; cosmetic self-tanning preparations; self -tanning creams and lotions for cosmetic purposes; suntan creams, lotions, oils and gels; non-medicated skin rejuvenation preparations, namely, creams, lotions, moisturizers, gels, balms, serums, oils, toners, cleaners and peels; non-medicated skin rejuvenation products, namely, creams, lotions, moisturizers, gels, balms, serums, oils, toners, cleaners and peels with and without analogues of alpha-melanocyte stimulating hormone (alpha-MSH); non-medicated antiaging skincare preparations; antiaging creams, lotions, moisturizers, gels, balms and serums; skin cleansing creams, lotions, milks, foams, gels and masks for cosmetic purposes

5 Pharmaceuticals for use in dermatology, for skin care, for the treatment of skin and skin relating conditions and disorders, for the treatment of damaged skin and tissue, for the treatment of sunburn, for the protection of the dermis and epidermis, for skin wounds; pharmaceuticals for skin care and for the treatment of skin and skin relating conditions and disorders based on analogues of melanocyte stimulating hormone (MSH), in particular afamelanotide; pharmaceutical drugs for use in dermatology, for skin care, for the treatment of skin and skin relating conditions and disorders, for the treatment of damaged skin and tissue, for the treatment of sunburn, for the protection of the dermis and epidermis, for skin wounds; pharmaceutical drugs for skin care and for the treatment of skin and skin relating conditions and disorders based on analogues of melanocyte stimulating hormone (MSH), in particular afamelanotide; pharmaceutical preparations for use in dermatology, for skin care, for the treatment of skin and skin relating conditions and disorders, for the treatment of damaged skin and tissue, for the treatment of sunburn, for the protection of the dermis and epidermis, for skin wounds; pharmaceutical preparations for skin care and for the treatment of skin and skin relating conditions and disorders based on analogues of melanocyte stimulating hormone (MSH), in particular afamelanotide; sun tanning preparations for pharmaceutical purposes, containing analogues of melanocyte stimulating hormone (MSH), in particular afamelanotide; sun tanning preparations for pharmaceutical purposes, not containing analogues of melanocyte stimulating hormone (MSH), in particular afamelanotide; medicated dermatological preparations; dermatological pharmaceutical substances; dermatological pharmaceutical products; medicinal creams for the protection of the skin; skin care creams for medical use; skin care preparations for medical use; medicated skin creams and lotions; medicated creams for application after exposure to the sun; pharmaceutical skin lotions; preparations for cleansing the skin for medical use; chemical and biological preparations, substances, reagents and compounds for use in dermatology, for skin care, for the treatment of skin and skin relating conditions and disorders, for the treatment of damaged skin and tissue, for the treatment of sunburn, for the protection of the dermis and epidermis, for skin wounds, all used for the delivery and storage of pharmaceuticals containing analogues of melanocyte stimulating hormone (MSH), in particular afamelanotide

The wording "T'SUMOYL" has no meaning in a foreign language.

Trademark Events

Mar 27, 2020

Final Decision Transaction Processed By Ib

Mar 11, 2020

Final Disposition Notice Sent To Ib

Mar 11, 2020

Final Disposition Processed

Feb 19, 2020

Final Disposition Notice Created, To Be Sent To Ib

Nov 19, 2019

Registered-Principal Register

Sep 3, 2019

Official Gazette Publication Confirmation E-Mailed

Sep 3, 2019

Published For Opposition

Aug 30, 2019

Notification Processed By Ib

Aug 14, 2019

Notification Of Possible Opposition Sent To Ib

Aug 14, 2019

Notice Of Start Of Opposition Period Created, To Be Sent To Ib

Aug 14, 2019

Notification Of Notice Of Publication E-Mailed

Jul 29, 2019

Approved For Pub - Principal Register

Jul 20, 2019

Teas/Email Correspondence Entered

Jul 20, 2019

Correspondence Received In Law Office

Jul 16, 2019

Assigned To Lie

Jul 11, 2019

Teas Response To Office Action Received

Feb 2, 2019

Refusal Processed By Ib

Jan 17, 2019

Non-Final Action Mailed - Refusal Sent To Ib

Jan 17, 2019

Refusal Processed By Mpu

Jan 5, 2019

Non-Final Action (Ib Refusal) Prepared For Review

Jan 4, 2019

Non-Final Action Written

Dec 28, 2018

Assigned To Examiner

Nov 30, 2018

Application Filing Receipt Mailed

Nov 26, 2018

New Application Office Supplied Data Entered In Tram

Nov 22, 2018

Sn Assigned For Sect 66a Appl From Ib